JS
Jonathan David Schwartz
See Remarks

Jonathan David Schwartz insider trades: Rocket Pharmaceuticals (RCKT) stock sales

See Remarks, Rocket Pharmaceuticals Last trade Nov 18, 2025 22 Form 4 filings
$8K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2022
2
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jonathan reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 18, 2025RCKT↓ Sell$8K
Aug 19, 2025RCKT↓ Sell$8K
Aug 14, 2025RCKT↓ Sell$34K
May 20, 2025RCKT↓ Sell$5K
May 16, 2025RCKT↓ Sell$10K
Feb 25, 2025RCKT↓ Sell$224K
Feb 17, 2023RCKT↓ Sell$68K
Mar 30, 2022RCKT↓ Sell$739K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other RCKT insiders

Open-market trades in the last 12 months

About Jonathan David Schwartz's insider trades

Jonathan David Schwartz is See Remarks at Rocket Pharmaceuticals (RCKT). Since Mar 30, 2022, Jonathan has reported no open-market purchases and 8 sales worth $1.1M on SEC Form 4. In the last 12 months: 1 sale ($8K).

Their filings also include grants and awards (11 filings), shares returned to the company (3 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RCKT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.